HeartSciences Inc. (HSCS)
 NASDAQ: HSCS · Real-Time Price · USD
 2.930
 -0.120 (-3.93%)
  At close: Nov 3, 2025, 4:00 PM EST
2.960
 +0.030 (1.02%)
  After-hours: Nov 3, 2025, 4:00 PM EST
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees 
 15
Change (1Y) 
 n/a
Growth (1Y) 
 n/a
Revenue / Employee 
 $417
Profits / Employee 
 -$584,569
Market Cap 
8.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Apr 30, 2025 | 15 | 0 | - | 
| Apr 30, 2024 | 15 | 3 | 25.00% | 
| Apr 30, 2023 | 12 | 0 | - | 
| Apr 30, 2022 | 12 | - | - | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
HSCS News
- 7 weeks ago - HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results - GlobeNewsWire
 - 2 months ago - HeartSciences Announces Conference Participation and Investor Webinar - GlobeNewsWire
 - 3 months ago - HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results - GlobeNewsWire
 - 5 months ago - HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis - GlobeNewsWire
 - 5 months ago - Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value - GlobeNewsWire
 - 5 months ago - HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone - GlobeNewsWire
 - 5 months ago - HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 - GlobeNewsWire
 - 6 months ago - HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson - GlobeNewsWire